Treatment-specific changes in decentering following mindfulness-based cognitive therapy versus antidepressant medication or placebo for prevention of depressive relapse.
Journal of Consulting and Clinical Psychology March 12, 2012 Peter Bieling, Lance L. Hawley, Richard T. Bloch et al. 239 citations
Mindfulness-based cognitive therapy (MBCT) fosters metacognitive skills—specifically the ability to decenter from thoughts and feelings and to approach them with curiosity—that are not acquired through antidepressant medication alone. In a randomized trial, patients who discontinued antidepressants and received MBCT showed significant increases in decentering and wider experiences, while those who continued medication or switched to placebo did not. These skills predicted lower depression scores at 6-month follow-up. The findings suggest that MBCT's effectiveness for preventing depressive relapse may stem from cultivating a decentered, curious stance toward one's own mental events.